If the drug proves to be efficacious for Covid treatment, Glenmark
will enjoy first mover advantage.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/will-the-launch-of-favipiravir-mark-the-turnaround-for-glenmark-pharma/articleshow/76498905.cms
No comments:
Post a Comment